The European Commission refers lecanemab decision to Appeal Committee
Go back to The European Commission refers lecanemab decision to Appeal Committee| BARNES GROUP, Inc. (NYSE: B) | Delayed: 41.60 +0.69 (1.69%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.91 | 52 Week High | $44.27 | |||
| Open | $41.33 | 52 Week Low | $30.07 | |||
| Day High | $41.94 | P/E | 31.76 | |||
| Day Low | $41.19 | EPS | $1.31 | |||
| Volume | 8,350,690 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 10.60 +0.17 (1.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.43 | 52 Week High | $8.73 | |||
| Open | $10.37 | 52 Week Low | $2.86 | |||
| Day High | $10.63 | P/E | N/A | |||
| Day Low | $10.10 | EPS | $-3.82 | |||
| Volume | 444,369 | |||||
